Safety and Efficacy of 90Y-FAPI-46 Radioligand Therapy in Patients with Advanced Sarcoma and Other Cancer EntitiesWolfgang P. Fendler, Rainer Hamacher, Kim M. Pabst et al.|Clinical Cancer Research|2022Cited by 145
Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor EntitiesNader Hirmas, Wolfgang P. Fendler, Hubertus Hautzel et al.|Journal of Nuclear Medicine|2022Cited by 68
Superior Tumor Detection for<sup>68</sup>Ga-FAPI-46 Versus<sup>18</sup>F-FDG PET/CT and Conventional CT in Patients with CholangiocarcinomaKim M. Pabst, Wolfgang P. Fendler, Marija Trajkovic‐Arsic et al.|Journal of Nuclear Medicine|2023Cited by 63
Casein kinase II inhibition induces apoptosis in pancreatic cancer cellsRainer Hamacher, Günter Schneider|Oncology Reports|2007Cited by 40
<sup>68</sup>Ga-Fibroblast Activation Protein Inhibitor PET/CT Improves Detection of Intermediate and Low-Grade Sarcomas and Identifies Candidates for Radiopharmaceutical TherapyHelena Lanzafame, Wolfgang P. Fendler, Ilektra A. Mavroeidi et al.|Journal of Nuclear Medicine|2024Cited by 36